NDC 68727-745-02
VYXEOS 100 mg/20mL
(daunorubicin and cytarabine) liposome · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
VYXEOS is a injection, powder, lyophilized, for suspension containing (daunorubicin and cytarabine) liposome at a strength of 100 mg/20mL. Manufactured by Jazz Pharmaceuticals, Inc..
Key Facts
- Brand Name
- VYXEOS
- Generic Name
- (daunorubicin and cytarabine) liposome
- NDC Code (Package)
68727-745-02- NDC Code (Product)
68727-745- Manufacturer
- Jazz Pharmaceuticals, Inc.
- Strength
- 100 mg/20mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA209401
- Drug Class
- Nucleoside Metabolic Inhibitor [EPC]; Anthracycline Topoisomerase Inhibitor [EPC]
- Marketing Start
- 08/03/2017
Recall History
No Recall HistoryView Full Drug Page
VYXEOS — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.